Literature DB >> 16410924

[Hepatitis B and C serologic markers in blood donors of the Ribeirão Preto Blood Center].

Vanderléia Bárbaro Valente1, Dimas Tadeu Covas, Afonso Dinis Costa Passos.   

Abstract

The investigation involved 25,891 blood donors who attended for the first time the Blood Center of Ribeirão Preto, Brazil, between Jun 23, 1996 and Jun 22, 2001. The objective was to study the proportion of positive serological markers for hepatitis B and C at the initial screening tests and to estimate the prevalence of such infections through the analysis of confirmatory tests, carried out at the University Hospital as a part of the patients evaluation. Data from the donors and laboratory results were obtained from the records of both the Blood Bank and the Hospital. The population of donors was mainly composed by males (83.6%) and by individuals between 26 and 45 (64%) years of age. The proportions of positive results in screening tests were 0.6% (CI95%: 0.54-0.72) for HBsAg and 1.2% (CI95%: 1.02-1.28) for anti-HCV. Confirmatory testes showed values of prevalence of 0.2% (CI95%: 0.16-0.28) for hepatitis B and 0.3% (IC95%: 0.24-0.38) for hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410924     DOI: 10.1590/s0037-86822005000600008

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  10 in total

1.  Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units.

Authors:  João Galizzi F; Rosângela Teixeira; José C F Fonseca; Francisco J D Souto
Journal:  Hepatol Int       Date:  2010-06-11       Impact factor: 6.047

2.  Factors associated with failure of clinical screening among blood donors who have altered serological results in the Centro Regional de Hemoterapia de Ribeirão Preto.

Authors:  Oranice Ferreira; Afonso Dinis Costa Passos
Journal:  Rev Bras Hematol Hemoter       Date:  2012

3.  Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.

Authors:  Cesar de Almeida-Neto; Ester Cerdeira Sabino; Jing Liu; Paula Fraiman Blatyta; Alfredo Mendrone-Junior; Nanci Alves Salles; Silvana Carneiro Leão; David J Wright; Fernando Valadares Basques; João Eduardo Ferreira; Michael P Busch; Edward L Murphy
Journal:  Transfusion       Date:  2012-08-06       Impact factor: 3.157

4.  Blood discard rate and the prevalence of infectious and contagious diseases in blood donors from provincial towns of the state of Paraná, Brazil.

Authors:  Sueli Donizete Borelli; Jocimara Costa Mazzola; Alessandra Cristina Gobbi Matta; Angélica Yukari Takemoto; Marta Bértoli
Journal:  Rev Bras Hematol Hemoter       Date:  2013

5.  The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020.

Authors:  Gulnar Azevedo E Silva; Lenildo de Moura; Maria Paula Curado; Fabio da Silva Gomes; Ubirani Otero; Leandro Fórnias Machado de Rezende; Regina Paiva Daumas; Raphael Mendonça Guimarães; Karina Cardoso Meira; Iuri da Costa Leite; Joaquim Gonçalves Valente; Ronaldo Ismério Moreira; Rosalina Koifman; Deborah Carvalho Malta; Marcia Sarpa de Campos Mello; Thiago Wagnos Guimarães Guedes; Paolo Boffetta
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

6.  Seroprevalence of transfusion-transmissible infectious diseases at a hemotherapy service located in southwest Bahia, Brazil.

Authors:  Kelly Almeida Andrade Ferreira Rebouças; Flávio Marinho Narici; Manoel Neres Santos Junior; Nayara Silva de Macêdo Neres; Márcio Vasconcelos Oliveira; Cláudio Lima Souza
Journal:  Hematol Transfus Cell Ther       Date:  2019-06-17

7.  Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná.

Authors:  Heloise Skiavine Madeira; Claudinei Mesquita da Silva; Neila Cristina Scapini; Leyde Daiane de Peder; Jorge Juarez Vieira Teixeira
Journal:  Saudi Pharm J       Date:  2021-04-24       Impact factor: 4.330

8.  HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil.

Authors:  Anna S Nishiya; Cesar de Almeida-Neto; Suzete C Ferreira; Cecília S Alencar; Claudia Di-Lorenzo-Oliveira; José E Levi; Nanci A Salles; Alfredo Mendrone; Ester C Sabino
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

9.  Distribution of serological screening markers at a large hematology and hemotherapy center in Minas Gerais, Southeastern Brazil.

Authors:  Sônia Mara Nunes da Silva; Milena Batista de Oliveira; Edson Zangiacomi Martinez
Journal:  Rev Bras Hematol Hemoter       Date:  2016-06-11

10.  Phylogenetic analysis of the emergence of main hepatitis C virus subtypes in São Paulo, Brazil.

Authors:  Anna Shoko Nishiya; César de Almeida-Neto; Camila Malta Romano; Cecília Salete Alencar; Suzete Cleusa Ferreira; Claudia Di-Lorenzo-Oliveira; José Eduardo Levi; Nanci Alves Salles; Alfredo Mendrone-Junior; Ester Cerdeira Sabino
Journal:  Braz J Infect Dis       Date:  2015-08-19       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.